Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Sell
11,171
-50
-0.4% -$13.5K 1.49% 15
2025
Q4
$3.32M Sell
11,221
-779
-6% -$233K 1.82% 9
2025
Q3
$3.39M Sell
12,000
-50
-0.4% -$13.1K 1.94% 8
2025
Q2
$3.55M Sell
12,050
-214
-2% -$55.1K 2.23% 7
2025
Q1
$3.05M Buy
12,264
+4
+0% +$978 2.21% 7
2024
Q4
$2.7M Sell
12,260
-300
-2% -$66.8K 1.91% 9
2024
Q3
$2.78M Sell
12,560
-1,250
-9% -$245K 1.92% 8
2024
Q2
$2.39M Sell
13,810
-45
-0.3% -$7.82K 1.73% 10
2024
Q1
$2.65M Sell
13,855
-375
-3% -$68.4K 1.94% 9
2023
Q4
$2.33M Sell
14,230
-250
-2% -$37.8K 1.83% 9
2023
Q3
$2.03M Hold
14,480
1.78% 12
2023
Q2
$1.94M Hold
14,480
1.68% 10
2023
Q1
$1.9M Buy
14,480
+4,025
+38% +$538K 1.71% 12
2022
Q4
$1.47M Sell
10,455
-3,525
-25% -$486K 1.47% 18
2022
Q3
$1.66M Sell
13,980
-450
-3% -$59.1K 1.8% 11
2022
Q2
$2.04M Sell
14,430
-2,405
-14% -$325K 2.04% 8
2022
Q1
$2.19M Buy
16,835
+4,850
+40% +$633K 1.77% 11
2021
Q4
$1.6M Buy
+11,985
New +$1.5M 1.28% 20

Other funds holding IBM

Cladis Investment Advisory's IBM Position: Q1 2026 in Review

Cladis Investment Advisory reduced its IBM (IBM) stake by 0.45% in Q1 2026, selling an estimated $13.5K and leaving 11,171 shares worth $2.71M. The position accounts for 1.49% of the portfolio, ranked #15.

Cladis Investment Advisory first reported a position in IBM in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.55M in Q2 2025. 3,462 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • Cladis Investment Advisory held 11,171 shares of IBM worth $2.71M as of Q1 2026.
  • Cladis Investment Advisory sold 50 IBM shares in Q1 2026, an estimated $13.5K.
  • IBM made up 1.49% of Cladis Investment Advisory's portfolio in Q1 2026, its #15 holding.
  • Cladis Investment Advisory first reported a position in IBM in Q4 2021 and has held it in 18 quarters since.
  • Cladis Investment Advisory's IBM position peaked at $3.55M in Q2 2025.
  • 3,462 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on Cladis Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.